ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
E300
|
132 |
42K |
7 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
42K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
E300
|
132 |
42K |
15 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
42K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
E300
|
1.3K |
409K |
17 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
1.3K
|
409K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
E300
|
943 |
408K |
7 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
943
|
408K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
E300
|
199 |
74K |
2 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
199
|
74K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
1.0K |
442K |
36 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
442K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
1.0K |
442K |
11 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
442K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
E300
|
225 |
85K |
10 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
85K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
E300
|
88 |
35K |
15 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
88
|
35K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
E300
|
245 |
96K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
245
|
96K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
E300
|
245 |
96K |
21 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
96K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
E300
|
245 |
96K |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
96K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
E300
|
675 |
306K |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
675
|
306K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
1.0K |
442K |
11 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
442K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
10K |
3.4M |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
10K
|
3.4M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
E300
|
236 |
98K |
13 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
236
|
98K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
10K |
3.4M |
14 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
10K
|
3.4M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
E300
|
1.3K |
409K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.3K
|
409K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
10K |
3.4M |
21 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
10K
|
3.4M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
E300
|
236 |
98K |
9 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
98K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
E300
|
236 |
98K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
98K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
1.0K |
442K |
9 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
1.0K
|
442K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
1.0K |
442K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
442K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
E300
|
226 |
84K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
84K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
10K |
3.4M |
11 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
10K
|
3.4M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
E300
|
166 |
52K |
4 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
166
|
52K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
48K |
3 |
25/12/23 |
25/12/23 |
ASX - By Stock
|
185
|
48K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
48K |
2 |
25/12/23 |
25/12/23 |
ASX - By Stock
|
185
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
48K |
8 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
185
|
48K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
48K |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
48K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
48K |
6 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
48K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2023 Full Year Financial Results Webcast
|
|
E300
|
60 |
30K |
8 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
60
|
30K
|
8
|
|
ASX - By Stock
|
AMA |
Re:
Ann: Completion of Placement and Institutional Entitlement Offer
|
|
E300
|
36 |
14K |
2 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
36
|
14K
|
2
|
|
ASX - By Stock
|
AMA |
Re:
Cash Flow & Statutory P&L
|
|
E300
|
5 |
1.7K |
4 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
5
|
1.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
E300
|
913 |
297K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
913
|
297K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
565K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
565K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
565K |
34 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
565K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
565K |
7 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
565K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.2M |
16 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.2M |
27 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.2M |
15 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
E300
|
905 |
291K |
5 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
905
|
291K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
E300
|
905 |
291K |
16 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
905
|
291K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
E300
|
400 |
155K |
10 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
155K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
E300
|
400 |
155K |
6 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
155K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
E300
|
5.8K |
2.9M |
10 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
5.8K
|
2.9M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
18K |
7.0M |
14 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
18K
|
7.0M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
18K |
7.0M |
18 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
18K
|
7.0M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.2M |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G, Appendix 3H and Appendix 3Ys
|
|
E300
|
24 |
13K |
18 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
24
|
13K
|
18
|
|